Research

The research curriculum outlined here is abbreviated and evolving. The current research focus of YENL is to identify molecular markers and driver genetic/epigenetic changes in a variety of endocrine tumors including, but not limited to:

• Adrenal Tumors
  • Adrenocortical adenoma
  • Adrenocortical carcinoma
  • Pheochromocytoma
• Endocrine Pancreatic tumors
• Parathyroid tumors
• Thyroid tumors
  • Anaplastic thyroid carcinoma
  • Follicular thyroid adenoma
  • Follicular thyroid carcinoma
  • Papillary thyroid carcinoma
• Other endocrine tumors

A key component behind the success of the YENL research efforts is the high volume and the excellent endocrine surgical practice at the Yale-New Haven Hospital. All patients seen at the endocrine surgery clinic will be offered to enroll in studies conducted by the YENL. This involves:

• Careful clinical, pathological and biochemical characterization of the disease,
• Cataloging of patient characteristics for each patient group, and
• Opportunity to enroll in a translational or reverse-translational research study.